Carvolix SA (CVX)
Euronext
Closed
Aug 25, 2026
Day's Range
6.4852 wk Range
1.82Overview - CVX - Carvolix SA
Key Statistics
Valuation
Enterprise Value
395.97M
P/E (Trailing)
‪-19.34‬
P/E (Forward)
‪-13.40‬
PEG Ratio
‪-13.40‬
Price / Sales (TTM)
‪421.81‬
Price / Book
‪11.38‬
EV / EBITDA
‪-32.38‬
Profitability
Profit Margin
‪20.78%‬
Operating Margin
‪-2,469.04%‬
Return on Assets
‪-24.21%‬
Return on Equity
‪-48.69%‬
Ownership
Shares Outstanding
39.26M
Held by Insiders
‪18.27%‬
Held by Institutions
‪65.62%‬
Price stats
Beta
‪1.10‬
50-Day Avg
‪5.29‬
200-Day Avg
‪3.32‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
4 analysts
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CVX - Carvolix SA
Peers - CVX - Carvolix SA
Peer Comparison
Compared with companies in Medical Devices listed on Euronext.
- CVXEuronextCarvolix SA380.87MMarket Cap+74.93%52-week change-19.35P/E (Trailing)‪20.78%‬Profit Margin
- PHIAEuronextKoninklijke Philips N.V.23.07BMarket Cap-1.06%52-week change20.71P/E (Trailing)‪6.30%‬Profit Margin
- IDLEuronextID Logistics Group SA2.21BMarket Cap-25.66%52-week change38.04P/E (Trailing)‪1.69%‬Profit Margin
- NANOEuronextNanobiotix S.A.1.73BMarket Cap+78.44%52-week change—P/E (Trailing)‪-73.51%‬Profit Margin
- IBABEuronextIon Beam Applications SA459.99MMarket Cap+22.73%52-week change37.71P/E (Trailing)‪2.05%‬Profit Margin
- CVCVEuronextZCI Limited317.47MMarket Cap+45.05%52-week change—P/E (Trailing)‪-186.77%‬Profit Margin
- AFMEEuronextAffluent Medical S.A.240.50MMarket Cap+76.80%52-week change-19.24P/E (Trailing)‪-279.96%‬Profit Margin
Profile Summary - CVX - Carvolix SA
About
Carvolix SA is a French clinical-stage medical technology company specializing in the development of AI-based mini-robots and biomimetic implants for cardiovascular treatments. Formed in early 2026 through the merger of Affluent Medical with Caranx Medical and Artedrone, it focuses on revolutionizing transcatheter…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
